BD-PEPFAR Lab Strengthening Partnership Assessment


BD-PEPFAR Laboratory Strengthening Partnership Assessment



In 2007, OGAC and Becton, Dickinson and Company (BD), a U.S.-based medical technology company, combined their respective strengths, experience, methodologies, and resources to pursue a public-private partnership (PPP).

The BD-PEPFAR Laboratory Strengthening Partnership was coordinated by the International Laboratory Branch of CDC on behalf of OGAC, and supported specific laboratory strengthening projects relevant to TB and HIV/AIDS treatment and care in PEPFAR countries. The partnership was implemented in Ethiopia, Uganda, Mozambique and South Africa.

The partnership is concluded its fifth year of implementation in 2012 and OGAC commissioned Cardno to conduct a third-party assessment of the PPP. The P4 Project conducted the assessment utilizing its tools and quantitative-based methodologies.

The assessment documented the value added of the partnership in terms of BD and PEPFAR shared goals and objectives, resources leveraged, and the results achieved through the partnership. The assessment documented potential opportunities for scale-up and replication of PPPs. Finally, the assessment distilled the lessons learned from the partnership and provided recommendations on how these lessons can be transferred to the partnership’s second phase, Labs for Life, launched at the International AIDS Conference 2012.

For more information on the BD-PEPFAR Laboratory Strengthening Partnership visit: BD Global Health Initiative and BD-PEPFAR Lab Strengthening Partnership.

BD-PEPFAR Laboratory Strengthening Assessment Executive Summary


Contact: For more information, contact Ophelia McMurray at [email protected]